GESTIPHARMA
ActiveSummary
GESTIPHARMA has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €815,663 and a net result of €77,529. Equity is shrinking by about 5.3% per year across the filed financial years. Its solvency ranks better than 92% of 10,582 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Directors
No directors read yet: 0 of 9 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.